Comparison Between a Robotic Tele-echo-cardiography Technique and a Standard Echocardiography in the Management of Heart Failure in the Guadeloupe Archipelago Between the University Hospital of Guadeloupe and the Marie-Galante Hospital (NCT07265986)
🩺 Plain-English Summary (8th-Grade Level)
The TERdeblue-S study is a feasibility study of robotic remote echocardiography, not only in terms of technology but also in terms of its integration into a telemedicine system to improve access to the heart failure management system in the Guadeloupe archipelago. The main objective of this study is to study the agreement of the measurement of the left ventricular ejection fraction (FejVG) between in situ echocardiography (EIS) and two-dimensional remote echocardiography (TER) (distance and volumes).
Who can join: To join this study, participants generally need to meet the listed inclusion criteria (7 items) and avoid the listed exclusions (4 items).
Location: Centre Hospitalier Sainte-Marie de Marie-Galante — Grand-Bourg
Age range: 18 Years
🧪 Interventions in This Study
- in situ echocardiography (EIS) (DIAGNOSTIC_TEST)
- two-dimensional remote echocardiography (TER) (DIAGNOSTIC_TEST)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistCheck every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).
Usually NOT eligible if any of the following apply:
- Exclusion Criteria:
- Patient requiring urgent cardiological management with transfer to the University Hospital
- Acute unstable heart failure, admission to CH Marie-Galante less than 5 days (less than one week)
- Pregnant women
🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.
📍 All Participating Trial Locations (3 Sites)
- Centre Hospitalier Sainte-Marie de Marie-Galante — Grand-Bourg,
- Centre de Cardiologie Zac Colin — Petit-Bourg,
- Cabinet de cardiologie TONCOEURTONKA — Petit-Canal,
📞 Contact the Study Coordinator
Phone: +590590934667
Email: melanie.petapermal@chu-guadeloupe.fr
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Heart Failure
- REDUCE LAP-HFREF TRIAL — New York, New York
- Physiological Effects Ketone Ester in Heart — Cleveland, Ohio
- Staged Kidney Transplantation During Combined Heart/Kidney Transplantation — Los Angeles, California
- Alleviant ALLAY-HFrEF Study — Los Angeles, California
- A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy — Birmingham, Alabama
Explore by condition: All Heart Failure clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.